表紙
市場調查報告書
商品編碼
1084059

慢性眼表疼痛的世界市場規模調查:各類藥物,各用途,各終端用戶,各地區預測(2022∼2028年)

Global Chronic Ocular Surface Pain Market Size study, By Drug Class (Antibiotics, Nonsteroidal Anti-Inflammatory, Corticosteroids, Others), By Application, By End-Users, and Regional Forecasts 2022-2028

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球慢性眼表疼痛市場,預計在2022∼2028年的預測期間內以健全成長率成長。

細菌性及病毒性的眼感染疾病的流行,老年人口增加,乾眼症增加,醫療費增加等,成為在全球促進市場需求的要素。可是,發展中國家的熟練專家不足和先進醫療設施的不足,預計阻礙預測期間的市場成長。

本報告提供全球慢性眼表疼痛市場相關調查分析,市場動態,產業分析,各藥物類別、用途、終端用戶、地區市場分析,企業簡介相關資訊。

目錄

第1章 摘要整理

第2章 全球慢性眼表疼痛市場定義和範圍

第3章 全球慢性眼表疼痛:市場動態

  • 慢性眼表疼痛市場影響分析(2020∼2028年)

第4章 全球慢性眼表疼痛市場:產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論
  • 主要投資機會
  • 主要制勝策略

第5章 風險評估:COVID-19影響

    • COVID-19對產業的整體影響的評估
    • COVID-19前及COVID-19後的市場情境

第6章 全球慢性眼表疼痛市場:各類藥物

  • 市場概述
  • 藥物類別,各效能-潛力分析
  • 市場估計與預測:各類藥物(2018∼2028年(100萬美元))
  • 子區隔分析
    • 抗生素
    • 非類固醇消炎劑(NSAID)
    • 皮質類固醇
    • 其他

第7章 全球慢性眼表疼痛市場:各用途

  • 市場概述
  • 用途,各效能-潛力分析
  • 市場估計與預測:各用途(2018∼2028年(100萬美元))
  • 子區隔分析
    • 鼻竇炎
    • 偏頭痛
    • 青光眼
    • 其他

第8章 全球慢性眼表疼痛市場:各終端用戶

  • 市場概述
  • 終端用戶,各效能-潛力分析
  • 市場估計與預測:各終端用戶(2018∼2028年(100萬美元))
  • 子區隔分析
    • 醫院
    • 專門診所
    • 居家護理
    • 其他

第9章 全球慢性眼表疼痛市場:地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • Pfizer Inc.
    • Novartis AG
    • Zydus Cadila
    • AstraZeneca
    • Johnson & Johnson
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • LEO Pharma A/S

第11章 調查流程

目錄

Global Chronic Ocular Surface Pain Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Chronic Ocular Surface Pain is a condition that occurs due to the damage of tissue at the ocular surface or from variations to central or peripheral nerves in the ocular surface sensory pathway. The rising prevalence of bacterial and viral ocular infections, increasing geriatric populations, and growing incidences of dry eyes among people, coupled with the rise in healthcare expenditure are several factors fostering the market demand across the globe. For instance, according to the World Health Organization (WHO), the geriatric population around the world is estimated to be over 524 million in 2010, and it is projected to increase to nearly 2 billion by 2050. Consequentially, aged people are more prone to suffer from various eye disorders, which, in turn, augment the market growth across the globe. However, the shortage of skilled professionals and the unavailability of advanced healthcare facilities in developing economies impede the growth of the market over the forecast period of 2022-2028. Also, a rise in the number of research and development activities and increasing drug approvals and launches are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Chronic Ocular Surface Pain Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing technological developments in diagnostic procedures and growing healthcare expenditure. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising prevalence of ocular diseases, as well as, rising presence of major generic manufacturers, would create lucrative growth prospects for the Chronic Ocular Surface Pain Market across the Asia-Pacific region.

Major market players included in this report are:

Pfizer Inc.

Novartis AG

Zydus Cadila

AstraZeneca

Johnson & Johnson

Bayer AG

Sun Pharmaceutical Industries Ltd.

Bristol-Myers Squibb Company

Eli Lilly and Company

LEO Pharma A/S

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Antibiotics

Nonsteroidal Anti-Inflammatory (NSAID)

Corticosteroids

Others

By Application:

Sinusitis

Migraines

Glaucoma

Others

By End-Users:

Hospitals

Specialty Clinics

Homecare

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Chronic Ocular Surface Pain Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Chronic Ocular Surface Pain Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Chronic Ocular Surface Pain Market, by Drug Class, 2020-2028 (USD Million)
    • 1.2.3. Chronic Ocular Surface Pain Market, by Application, 2020-2028 (USD Million)
    • 1.2.4. Chronic Ocular Surface Pain Market, by End-Users, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Chronic Ocular Surface Pain Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Ocular Surface Pain Market Dynamics

  • 3.1. Chronic Ocular Surface Pain Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of bacterial and viral ocular infections
      • 3.1.1.2. Growing geriatric populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. Shortage of skilled professionals
      • 3.1.2.2. Unavailability of advanced healthcare facilities in developing economies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rise in the number of research and development activities
      • 3.1.3.2. Increasing drug approvals and launches

Chapter 4. Global Chronic Ocular Surface Pain Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Chronic Ocular Surface Pain Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Chronic Ocular Surface Pain Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by Drug Class, 2018-2028 (USD Million)
  • 6.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 6.4.1. Antibiotics
    • 6.4.2. Nonsteroidal Anti-Inflammatory (NSAID)
    • 6.4.3. Corticosteroids
    • 6.4.4. Others

Chapter 7. Global Chronic Ocular Surface Pain Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Chronic Ocular Surface Pain Market by Application, Performance - Potential Analysis
  • 7.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
  • 7.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 7.4.1. Sinusitis
    • 7.4.2. Migraines
    • 7.4.3. Glaucoma
    • 7.4.4. Others

Chapter 8. Global Chronic Ocular Surface Pain Market, by End-Users

  • 8.1. Market Snapshot
  • 8.2. Global Chronic Ocular Surface Pain Market by End-Users, Performance - Potential Analysis
  • 8.3. Global Chronic Ocular Surface Pain Market Estimates & Forecasts by End-Users, 2018-2028 (USD Million)
  • 8.4. Chronic Ocular Surface Pain Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Specialty Clinics
    • 8.4.3. Homecare
    • 8.4.4. Others

Chapter 9. Global Chronic Ocular Surface Pain Market, Regional Analysis

  • 9.1. Chronic Ocular Surface Pain Market, Regional Market Snapshot
  • 9.2. North America Chronic Ocular Surface Pain Market
    • 9.2.1. U.S. Chronic Ocular Surface Pain Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-Users breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Chronic Ocular Surface Pain Market
  • 9.3. Europe Chronic Ocular Surface Pain Market Snapshot
    • 9.3.1. U.K. Chronic Ocular Surface Pain Market
    • 9.3.2. Germany Chronic Ocular Surface Pain Market
    • 9.3.3. France Chronic Ocular Surface Pain Market
    • 9.3.4. Spain Chronic Ocular Surface Pain Market
    • 9.3.5. Italy Chronic Ocular Surface Pain Market
    • 9.3.6. Rest of Europe Chronic Ocular Surface Pain Market
  • 9.4. Asia-Pacific Chronic Ocular Surface Pain Market Snapshot
    • 9.4.1. China Chronic Ocular Surface Pain Market
    • 9.4.2. India Chronic Ocular Surface Pain Market
    • 9.4.3. Japan Chronic Ocular Surface Pain Market
    • 9.4.4. Australia Chronic Ocular Surface Pain Market
    • 9.4.5. South Korea Chronic Ocular Surface Pain Market
    • 9.4.6. Rest of Asia Pacific Chronic Ocular Surface Pain Market
  • 9.5. Latin America Chronic Ocular Surface Pain Market Snapshot
    • 9.5.1. Brazil Chronic Ocular Surface Pain Market
    • 9.5.2. Mexico Chronic Ocular Surface Pain Market
  • 9.6. Rest of The World Chronic Ocular Surface Pain Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. Zydus Cadila
    • 10.2.4. AstraZeneca
    • 10.2.5. Johnson & Johnson
    • 10.2.6. Bayer AG
    • 10.2.7. Sun Pharmaceutical Industries Ltd.
    • 10.2.8. Bristol-Myers Squibb Company
    • 10.2.9. Eli Lilly and Company
    • 10.2.10. LEO Pharma A/S

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Chronic Ocular Surface Pain Market, report scope
  • TABLE 2. Global Chronic Ocular Surface Pain Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Chronic Ocular Surface Pain Market estimates & forecasts by Drug Class 2018-2028 (USD Million)
  • TABLE 4. Global Chronic Ocular Surface Pain Market estimates & forecasts by Application 2018-2028 (USD Million)
  • TABLE 5. Global Chronic Ocular Surface Pain Market estimates & forecasts by End-Users 2018-2028 (USD Million)
  • TABLE 6. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Chronic Ocular Surface Pain Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. Global Chronic Ocular Surface Pain Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 17. U.S. Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. U.S. Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 19. Canada Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 20. Canada Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. Canada Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 22. UK Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 23. UK Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. UK Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 25. Germany Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 26. Germany Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. Germany Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 28. RoE Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 29. RoE Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. RoE Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 31. China Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 32. China Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. China Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 34. India Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 35. India Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. India Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 37. Japan Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 38. Japan Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. Japan Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. RoAPAC Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 43. Brazil Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 44. Brazil Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Brazil Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 46. Mexico Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 47. Mexico Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. Mexico Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 49. RoLA Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 50. RoLA Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. RoLA Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 52. Row Chronic Ocular Surface Pain Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 53. Row Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. Row Chronic Ocular Surface Pain Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Chronic Ocular Surface Pain Market
  • TABLE 56. List of primary sources, used in the study of global Chronic Ocular Surface Pain Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Chronic Ocular Surface Pain Market, research methodology
  • FIG 2. Global Chronic Ocular Surface Pain Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Chronic Ocular Surface Pain Market, key trends 2021
  • FIG 5. Global Chronic Ocular Surface Pain Market, growth prospects 2022-2028
  • FIG 6. Global Chronic Ocular Surface Pain Market, porters 5 force model
  • FIG 7. Global Chronic Ocular Surface Pain Market, pest analysis
  • FIG 8. Global Chronic Ocular Surface Pain Market, value chain analysis
  • FIG 9. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Chronic Ocular Surface Pain Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Chronic Ocular Surface Pain Market, regional snapshot 2018 & 2028
  • FIG 15. North America Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Chronic Ocular Surface Pain market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Chronic Ocular Surface Pain Market 2018 & 2028 (USD Million)
  • FIG 19. Global Chronic Ocular Surface Pain Market, company market share analysis (2021)